title: Interventional cardiology: Indications for renal denervation: a balanced approach?
abstract: Renal denervation for the treatment of resistant hypertension is approved in Europe and is being studied in the USA. A newly published ESC consensus document integrates all the published data on this procedure, and summarizes how best to define, evaluate, and follow up patients who are candidates for the procedure.
authors.forename: George L
authors.initials: GL
authors.lastname: Bakris
mesh_terms: D000959:Antihypertensive Agents / Q000627:therapeutic use; D001794:Blood Pressure / Q000187:drug effects; D004351:Drug Resistance; D006801:Humans; D006973:Hypertension / Q000175:diagnosis / Q000503:physiopathology / Q000628:therapy*; D007668:Kidney / Q000294:innervation*; D018579:Patient Selection; D017410:Practice Guidelines as Topic; D012307:Risk Factors; D013562:Sympathectomy / Q000009:adverse effects / Q000379:methods / Q000592:standards; D016896:Treatment Outcome
chemical_list: D000959:Antihypertensive Agents